Semaglutide* Semaglutide is an FDA-approved injectable medication that was originally developed as a treatment for type 2 diabetes, but has been tremendously effective for weight loss
The protective effect of prenatally administered vitamin E on behavioral alterations in an animal model of autism induced by valproic acid
Among these advancements, nebulized glutathione emerges as a promising addition to the arsenal of respiratory interventions
The authors at Cornell University, US, also determined that policies restricting food choices are generally ineffective and decrease program participation, while expanding work requirements risks substantially increasing food insecurity with minimal employment gains
Patients should specifically inform their doctor if they have a history of the following conditions : thyroid disorders or thyroid nodules, pancreatitis or elevated pancreatic enzymes, kidney disease, liver disease, diabetic retinopathy, depression or suicidal ideation, gastroparesis or severe gastrointestinal disorders, or gallbladder disease